Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) EPS (Weighted Average and Diluted) (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.09 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) changed N/A to -$0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.61 through Dec 2025, changed N/A year-over-year, with the annual reading at -$1.51 for FY2025, N/A changed from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.09 at Adagio Medical Holdings, up from -$0.66 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.02 in Q3 2024, with the low at -$14.15 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$4.97, with a median of -$0.66 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 100.14% in 2024, then tumbled 3400.0% in 2025.
  • Over 3 years, EPS (Weighted Average and Diluted) stood at -$11.33 in 2023, then surged by 100.18% to $0.02 in 2024, then tumbled by 550.0% to -$0.09 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.09, -$0.66, and -$0.35 for Q4 2025, Q3 2025, and Q2 2025 respectively.